142 related articles for article (PubMed ID: 20967757)
21. Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistance, hyperinsulinemia, and increased adiposity.
Araújo EP; De Souza CT; Gasparetti AL; Ueno M; Boschero AC; Saad MJ; Velloso LA
Endocrinology; 2005 Mar; 146(3):1428-37. PubMed ID: 15550510
[TBL] [Abstract][Full Text] [Related]
22. p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance.
Hemi R; Yochananov Y; Barhod E; Kasher-Meron M; Karasik A; Tirosh A; Kanety H
Diabetes; 2011 Apr; 60(4):1134-45. PubMed ID: 21386087
[TBL] [Abstract][Full Text] [Related]
23. [Elucidation of a New Mechanism of Onset of Insulin Resistance: Effects of Statins and Tumor Necrosis Factor-α on Insulin Signal Transduction].
Takaguri A
Yakugaku Zasshi; 2018; 138(11):1329-1334. PubMed ID: 30381640
[TBL] [Abstract][Full Text] [Related]
24. The IRS/PI3K/Akt signaling pathway mediates olanzapine-induced hepatic insulin resistance in male rats.
Ren L; Zhou X; Huang X; Wang C; Li Y
Life Sci; 2019 Jan; 217():229-236. PubMed ID: 30550886
[TBL] [Abstract][Full Text] [Related]
25. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists.
Fernández-Veledo S; Vila-Bedmar R; Nieto-Vazquez I; Lorenzo M
J Clin Endocrinol Metab; 2009 Sep; 94(9):3583-93. PubMed ID: 19567513
[TBL] [Abstract][Full Text] [Related]
26. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.
Liang Q; Wiese RJ; Bueno OF; Dai YS; Markham BE; Molkentin JD
Mol Cell Biol; 2001 Nov; 21(21):7460-9. PubMed ID: 11585926
[TBL] [Abstract][Full Text] [Related]
27. Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways.
Liu K; Zhao W; Gao X; Huang F; Kou J; Liu B
Atherosclerosis; 2012 Aug; 223(2):350-8. PubMed ID: 22766331
[TBL] [Abstract][Full Text] [Related]
28. Effect of a p38 MAPK inhibitor on FFA-induced hepatic insulin resistance in vivo.
Pereira S; Yu WQ; Moore J; Mori Y; Tsiani E; Giacca A
Nutr Diabetes; 2016 May; 6(5):e210. PubMed ID: 27136448
[TBL] [Abstract][Full Text] [Related]
29. Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3-kinase-mediated signaling in rat liver.
Carvalheira JB; Ribeiro EB; Folli F; Velloso LA; Saad MJ
Biol Chem; 2003 Jan; 384(1):151-9. PubMed ID: 12674509
[TBL] [Abstract][Full Text] [Related]
30. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.
Muñoz MC; Argentino DP; Dominici FP; Turyn D; Toblli JE
J Hypertens; 2006 Aug; 24(8):1607-17. PubMed ID: 16877964
[TBL] [Abstract][Full Text] [Related]
31. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
32. Role for mitogen-activated protein kinases in phenobarbital-induced expression of cytochrome P450 2B in primary cultures of rat hepatocytes.
Joannard F; Rissel M; Gilot D; Anderson A; Orfila-Lefeuvre L; Guillouzo A; Atfi A; Lagadic-Gossmann D
Toxicol Lett; 2006 Feb; 161(1):61-72. PubMed ID: 16154717
[TBL] [Abstract][Full Text] [Related]
33. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome.
Corbould A; Zhao H; Mirzoeva S; Aird F; Dunaif A
Diabetes; 2006 Mar; 55(3):751-9. PubMed ID: 16505239
[TBL] [Abstract][Full Text] [Related]
34. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
[TBL] [Abstract][Full Text] [Related]
35. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins.
Qin B; Qiu W; Avramoglu RK; Adeli K
Diabetes; 2007 Feb; 56(2):450-61. PubMed ID: 17259391
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-alpha.
Ma Y; Toth B; Keeton AB; Holland LT; Chaudry IH; Messina JL
Endocrinology; 2004 Nov; 145(11):5168-76. PubMed ID: 15297437
[TBL] [Abstract][Full Text] [Related]
38. Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats.
Ling PR; Mueller C; Smith RJ; Bistrian BR
Metabolism; 2003 Jul; 52(7):868-74. PubMed ID: 12870163
[TBL] [Abstract][Full Text] [Related]
39. Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes.
Henkel J; Neuschäfer-Rube F; Pathe-Neuschäfer-Rube A; Püschel GP
Hepatology; 2009 Sep; 50(3):781-90. PubMed ID: 19575453
[TBL] [Abstract][Full Text] [Related]
40. SHP2 knockdown ameliorates liver insulin resistance by activating IRS-2 phosphorylation through the AKT and ERK1/2 signaling pathways.
Yue X; Han T; Hao W; Wang M; Fu Y
FEBS Open Bio; 2020 Dec; 10(12):2578-2587. PubMed ID: 33012117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
